agneta nordberg

Prof. agneta nordberg

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2004 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
BWB. Winblad
B. Winblad
KPKatie Palmer
Katie Palmer
MKM. Kivipelto
M. Kivipelto
VJV. Jelic
V. Jelic
LFL. Fratiglioni
L. Fratiglioni
RPR.C. Petersen
R.C. Petersen
: The First Key Symposium was held in Stockholm, Sweden, 2–5 September 2003. The aim of the symposium was to integrate clinical and epidemiological perspectives on the topic of Mild Cognitive Impairment (MCI). A multidisciplinary, international group of experts discussed the current status and future directions of MCI, with regard to clinical presentation, cognitive and functional assessment, and the role of neuroimaging, biomarkers and genetics. Agreement on new perspectives, as well as recommendations for management and future research were discussed by the international working group. The specific recommendations for the general MCI criteria include the following: (i) the person is neither normal nor demented; (ii) there is evidence of cognitive deterioration shown by either objectively measured decline over time and/or subjective report of decline by self and/or informant in conjunction with objective cognitive deficits; and (iii) activities of daily living are preserved and complex instrumental functions are either intact or minimally impaired.

21 January 2004 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
WKWilliam E. Klunk
William E. Klunk
HEHenry Engler
Henry Engler
ANagneta nordberg
agneta nordberg
YWYanming Wang
Yanming Wang
GBGunnar Blomqvist
Gunnar Blomqvist
BLBengt Långström
Bengt Långström

1 June 2014 in The Lancet Neurology
Verified
Journal Article
Closed access
BDBruno Dubois
Bruno Dubois
HFHoward H Feldman
Howard H Feldman
CJClaudia Jacova
Claudia Jacova
HHHarald Hampel
Harald Hampel
JMJosé Luis Molinuevo
José Luis Molinuevo
JCJeffrey L Cummings
Jeffrey L Cummings

1 April 2016 in The Lancet Neurology
Verified
Journal Article
Closed access
BWBengt Winblad
Bengt Winblad
PAPhilippe Amouyel
Philippe Amouyel
SASandrine Andrieu
Sandrine Andrieu
CBClive Mr. Ballard
Clive Mr. Ballard
CBCarol Brayne
Carol Brayne
HZHenrik Zetterberg
Henrik Zetterberg

19 May 2015 in JAMA
Verified
Journal Article
Open access
PDF file
WJWillemijn J. Jansen
Willemijn J. Jansen
RORik Ossenkoppele
Rik Ossenkoppele
DKDirk L. Knol
Dirk L. Knol
BTBetty Tijms
Betty Tijms
PSPhilip Scheltens
Philip Scheltens
HZHenrik Zetterberg
Henrik Zetterberg
Alzheimer disease (AD) is the most common cause of dementia, with a worldwide prevalence of about 25 million in 2010, expected to be doubled by 2030 because of increased life expectancy.1 The earliest recognizable pathological event in AD is cerebral amyloid-β aggregation.2 This pathology may be present up to 20 years before the onset of dementia.3,4 Novel research criteria for AD in individuals without dementia emphasize the presence of amyloid pathology to define the first stage of the disease.5,6

1 May 2000 in Progress in Neurobiology
Verified
Journal Article
Closed access
DPDavid Paterson
David Paterson
ANagneta nordberg
agneta nordberg